Filippo Ansaldi

Best Publications

• Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy

  Unknown

  213
  Citations

• Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

  Maria Pia Sormani;Matilde Inglese;Irene Schiavetti;Luca Carmisciano

  212
  Citations

• Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy

  Unknown

  193
  Citations

• Influenza control in the 21st century: Optimizing protection of older adults.

  Arnold S. Monto;Filippo Ansaldi;Richard Aspinall;Janet E. McElhaney;Janet E. McElhaney

  173
  Citations

• Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors.

  Unknown

  150
  Citations

• Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.

  Filippo Ansaldi;Sabrina Bacilieri;Paolo Durando;Laura Sticchi

  146
  Citations

• Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

  Unknown

  143
  Citations

• Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

  Filippo Ansaldi;Marta Zancolli;Paolo Durando;Emanuele Montomoli

  134
  Citations

• Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen

  Unknown

  130
  Citations

• Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens

  Davide Bedognetti;Gabriele Zoppoli;Gabriele Zoppoli;Carlotta Massucco;Elisa Zanardi;Elisa Zanardi

  114
  Citations

• Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey.

  Alexander Domnich;Maura Cambiaggi;Alessandro Vasco;Luca Maraniello

  114
  Citations

• Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy.

  Paolo Durando;Pietro Crovari;Filippo Ansaldi;Laura Sticchi

  106
  Citations

• Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

  P. Durando;D. Fenoglio;A. Boschini;F. Ansaldi

  99
  Citations

• MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

  Unknown

  96
  Citations

• Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells

  Michele Cea;Michele Cea;Debora Soncini;Floriana Fruscione;Lizzia Raffaghello

  95
  Citations

• Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

  Giuseppe Murdaca;Andrea Orsi;Francesca Spanò;Francesco Puppo

  92
  Citations

• Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

  Unknown

  89
  Citations

• Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.

  Gianna Dal Molin;Filippo Ansaldi;Claudia Biagi;Pierlanfranco D'Agaro

  86
  Citations

• Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

  Unknown

  84
  Citations

• The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis

  Unknown

  84
  Citations